AMEUF (Anteris Technologies) PB Ratio : 45.31 (As of Dec. 13, 2024)

View and export this data going back to 2006. Start your Free Trial

What is Anteris Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-13), Anteris Technologies's share price is $8.88. Anteris Technologies's Book Value per Share for the quarter that ended in Jun. 2024 was $0.20. Hence, Anteris Technologies's PB Ratio of today is 45.31.

Warning Sign:

Anteris Technologies Ltd stock PB Ratio (=35.73) is close to 10-year high of 35.73

The historical rank and industry rank for Anteris Technologies's PB Ratio or its related term are showing as below:

AMEUF' s PB Ratio Range Over the Past 10 Years
Min: 0.95 Med: 4.37 Max: 35.73
Current: 35.52

During the past 13 years, Anteris Technologies's highest PB Ratio was 35.73. The lowest was 0.95. And the median was 4.37.

AMEUF's PB Ratio is ranked worse than
98.6% of 786 companies
in the Medical Devices & Instruments industry
Industry Median: 2.335 vs AMEUF: 35.52

During the past 12 months, Anteris Technologies's average Book Value Per Share Growth Rate was -78.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 60.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Anteris Technologies was 60.70% per year. The lowest was -43.30% per year. And the median was -21.80% per year.

Back to Basics: PB Ratio

Anteris Technologies PB Ratio Historical Data

The historical data trend for Anteris Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies PB Ratio Chart

Anteris Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

3.98

9.95

10.26

23.99

12.29

Anteris Technologies Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
PB Ratio	Get a 7-Day Free Trial															12.48	23.99	15.28	12.29	66.07

Competitive Comparison of Anteris Technologies's PB Ratio

For the Medical Devices subindustry, Anteris Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anteris Technologies's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Anteris Technologies's PB Ratio falls into.

Anteris Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Anteris Technologies's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2024)
	=	8.88	/	0.196
	=	45.31

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Anteris Technologies (OTCPK:AMEUF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Anteris Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Anteris Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (OTCPK:AMEUF) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

AVR:Australia

Address

9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066

Website

https://www.anteristech.com

Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. It is also engaged in research and development of ComASUR, a delivery system that allows accurate valve placement, and the manufacturing and selling of proprietary ADAPT regenerative tissue products. The company generates a majority of its revenue from the United States and the rest from Switzerland and Australia.